Ergomed PLC
LSE:ERGO
Balance Sheet
Balance Sheet Decomposition
Ergomed PLC
Ergomed PLC
Balance Sheet
Ergomed PLC
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
9
|
4
|
4
|
3
|
5
|
14
|
19
|
31
|
19
|
|
| Cash |
0
|
4
|
0
|
4
|
3
|
5
|
14
|
19
|
31
|
19
|
|
| Cash Equivalents |
2
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
3
|
19
|
0
|
14
|
19
|
19
|
17
|
26
|
27
|
36
|
|
| Accounts Receivables |
3
|
16
|
0
|
12
|
16
|
16
|
15
|
25
|
22
|
33
|
|
| Other Receivables |
0
|
3
|
0
|
2
|
3
|
3
|
2
|
2
|
5
|
3
|
|
| Other Current Assets |
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
|
| Total Current Assets |
5
|
23
|
0
|
20
|
23
|
25
|
32
|
47
|
60
|
58
|
|
| PP&E Net |
0
|
1
|
0
|
1
|
1
|
1
|
6
|
6
|
5
|
5
|
|
| PP&E Gross |
0
|
1
|
0
|
1
|
1
|
1
|
6
|
6
|
5
|
5
|
|
| Accumulated Depreciation |
0
|
1
|
0
|
1
|
1
|
2
|
4
|
6
|
6
|
8
|
|
| Intangible Assets |
0
|
20
|
0
|
20
|
20
|
4
|
3
|
10
|
8
|
16
|
|
| Goodwill |
1
|
15
|
0
|
12
|
15
|
14
|
13
|
25
|
24
|
41
|
|
| Long-Term Investments |
0
|
1
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
2
|
0
|
1
|
2
|
1
|
3
|
5
|
9
|
9
|
|
| Other Assets |
1
|
15
|
0
|
12
|
15
|
14
|
13
|
25
|
24
|
41
|
|
| Total Assets |
7
N/A
|
62
+821%
|
0
N/A
|
54
N/A
|
62
+14%
|
47
-24%
|
57
+22%
|
92
+62%
|
106
+15%
|
129
+22%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
3
|
6
|
3
|
5
|
5
|
3
|
4
|
3
|
7
|
|
| Accrued Liabilities |
1
|
3
|
0
|
3
|
3
|
4
|
6
|
10
|
10
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
|
| Other Current Liabilities |
0
|
5
|
0
|
2
|
5
|
9
|
5
|
18
|
21
|
22
|
|
| Total Current Liabilities |
5
|
14
|
6
|
9
|
14
|
17
|
16
|
34
|
35
|
39
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
1
|
2
|
|
| Deferred Income Tax |
0
|
3
|
0
|
3
|
3
|
1
|
0
|
2
|
2
|
4
|
|
| Other Liabilities |
0
|
10
|
0
|
8
|
10
|
1
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
27
+463%
|
0
N/A
|
20
N/A
|
27
+37%
|
19
-32%
|
20
+9%
|
39
+95%
|
39
-2%
|
45
+15%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Retained Earnings |
2
|
13
|
0
|
16
|
13
|
3
|
10
|
52
|
66
|
80
|
|
| Additional Paid In Capital |
0
|
21
|
0
|
18
|
21
|
24
|
26
|
0
|
1
|
1
|
|
| Other Equity |
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
3
|
|
| Total Equity |
2
N/A
|
35
+1 724%
|
0
N/A
|
34
N/A
|
35
+1%
|
28
-19%
|
37
+30%
|
53
+44%
|
67
+27%
|
85
+26%
|
|
| Total Liabilities & Equity |
7
N/A
|
62
+821%
|
0
N/A
|
54
N/A
|
62
+14%
|
47
-24%
|
57
+22%
|
92
+62%
|
106
+15%
|
129
+22%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
29
|
43
|
0
|
41
|
43
|
45
|
47
|
49
|
49
|
50
|
|